Risk of refractory disease or relapse from complete remission for 701 patients with Hodgkin’s lymphoma seen in British Columbia during the 1990s who accepted initially planned standard treatment.*
| Stage . | n . | Refractory . | % of All with Refractory Disease . | Relapsed . | % of All with Relapsed Disease . |
|---|---|---|---|---|---|
| *Ten patients, all with limited-stage Hodgkin’s lymphoma, refused initially offered treatment and are not included in this analysis. | |||||
| Limited | 241 | 0 | 0 | 6 | 6 |
| Advanced | 460 | 32 | 100 | 87 | 94 |
| Stage . | n . | Refractory . | % of All with Refractory Disease . | Relapsed . | % of All with Relapsed Disease . |
|---|---|---|---|---|---|
| *Ten patients, all with limited-stage Hodgkin’s lymphoma, refused initially offered treatment and are not included in this analysis. | |||||
| Limited | 241 | 0 | 0 | 6 | 6 |
| Advanced | 460 | 32 | 100 | 87 | 94 |